Carmat is working to overcome financial struggles that forced it to suspend new device implants through the end of August. Even with its future in limbo, the company remains focused on moving forward.

The FDA previously shared an early alert about this issue, but it was still reviewing the situation at the time. The new recall covers a total of more than 11,000 devices.

We’ve looked at woke from all sides now. Woke AI, that is. It’s become a widely discussed thing, thanks to President Donald Trump’s July 23 executive order “Preventing Woke AI in the Federal Government.” 

The Wall Street Journal first reported news of the alleged impending ouster on July 25, citing anonymous sources. 

ACR recently made its case in a comment letter sent to Health and Human Services Secretary Robert F. Kennedy Jr., highlighting proposed legislation that could help. 

American Medical Association (AMA) Board of Trustees Member Scott Ferguson, MD, FACR, discusses how and why physicians are opting out of Medicare because the payments no longer are covering their costs. 

Stereotaxis has received FDA clearance for the first mapping catheter of its kind. The company emphasized that this is just the first of many robotically navigated devices it is working to bring to the U.S. market.

The province's Ministry of Economic Development, Job Creation and Trade had previously exhibited at the world's largest medical imaging conference.